Department of Medical and Surgical Sciences and Translational Medicine, St Andrea University Hospital, Sapienza University, Rome, Italy.
Digestive Surgery and Liver Transplantation Unit, Archet 2 Hospital, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, France.
Surgery. 2020 Sep;168(3):434-439. doi: 10.1016/j.surg.2020.04.030. Epub 2020 Jun 27.
Pancreatoduodenectomy with synchronous resection of the portal vein/superior mesenteric vein confluence may result in the development of left-sided portal hypertension. Left-sided portal hypertension presents with splenomegaly and varices and may cause severe gastrointestinal bleeding. The aim of the study is to review the incidence, treatment, and preventive strategies of left-sided portal hypertension.
A systematic literature search was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement to identify all studies published up to September 30, 2019 reporting data on patients with left-sided portal hypertension after pancreatoduodenectomy with venous resection.
Eight articles including 829 patients were retrieved. Left-sided portal hypertension occurred in 7.7% of patients who had splenic vein preservation and 29.4% of those having splenic vein ligation. Fourteen cases of gastrointestinal bleeding owing to left-sided portal hypertension were reported at a mean interval of 28 months from pancreatoduodenectomy. Related mortality at 1 month was 7.1%. Treatment of left-sided portal hypertension consisted of splenectomy in 3 cases (21%) and colectomy in 1 (7%) case, whereas radiologic, endoscopic procedures or conservative treatments were effective in the other cases (71%).
Left-sided portal hypertension represents a potentially severe complication of pancreatoduodenectomy with venous resection occurring at greater incidence when the splenic vein is ligated and not reimplanted. Left-sided portal hypertension-related gastrointestinal bleeding although rare can be managed depending on the situation by endoscopic, radiologic procedures or operative intervention with low related mortality.
胰十二指肠切除术伴门静脉/肠系膜上静脉汇合部切除可能导致左侧门静脉高压的发展。左侧门静脉高压表现为脾肿大和静脉曲张,并可能导致严重的胃肠道出血。本研究旨在回顾左侧门静脉高压的发生率、治疗和预防策略。
根据系统评价和荟萃分析的首选报告项目,进行系统文献检索,以确定截至 2019 年 9 月 30 日所有报道胰十二指肠切除术伴静脉切除术后发生左侧门静脉高压患者数据的研究。
共检索到 8 篇文章,包括 829 例患者。保留脾静脉的患者中有 7.7%发生左侧门静脉高压,结扎脾静脉的患者中有 29.4%发生左侧门静脉高压。术后 28 个月平均间隔报告了 14 例因左侧门静脉高压导致的胃肠道出血。术后 1 个月相关死亡率为 7.1%。左侧门静脉高压的治疗包括脾切除术 3 例(21%)和结肠切除术 1 例(7%),而其他病例(71%)经放射、内镜或保守治疗有效。
左侧门静脉高压是胰十二指肠切除术伴静脉切除术后一种潜在的严重并发症,当脾静脉结扎而不重新植入时,其发生率更高。虽然左侧门静脉高压相关的胃肠道出血很少见,但可根据具体情况通过内镜、放射或手术干预来治疗,相关死亡率较低。